Cristina Arias-Marcos

Bilbao, PV 48080, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Therapeutic Tools for Vulvovaginal Candidiasis: Current and Emerging Antifungal Agents.

Therapeutic Tools for Vulvovaginal Candidiasis: Current and Emerging Antifungal Agents.

Journal: Journal of fungi (Basel, Switzerland)

Published: January 14, 2026

Emergent Candida Species on Healthcare Surfaces: Abiotic Reservoirs as a Source of Invasive Candidiasis.

Emergent Candida Species on Healthcare Surfaces: Abiotic Reservoirs as a Source of Invasive Candidiasis.

Journal: Microorganisms

Published: December 30, 2025

Aetiology of Vulvovaginal Candidiasis in Ecuador and In Vitro Antifungal Activity Against Candida Vaginal Isolates.

Aetiology of Vulvovaginal Candidiasis in Ecuador and In Vitro Antifungal Activity Against Candida Vaginal Isolates.

Journal: Journal of fungi (Basel, Switzerland)

Published: August 29, 2025

The future of non-invasive azole antifungal treatment options for the management of vulvovaginal candidiasis.

The future of non-invasive azole antifungal treatment options for the management of vulvovaginal candidiasis.

Journal: Expert review of anti-infective therapy

Published: June 04, 2025

In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida: A European Study.

In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida: A European Study.

Journal: Frontiers in cellular and infection microbiology

Published: March 28, 2022

In vitro and in vivo anti-Candida activity of citral in combination with fluconazole.

In vitro and in vivo anti-Candida activity of citral in combination with fluconazole.

Journal: Journal of oral microbiology

Published: March 07, 2022

In vitro activities of carvacrol, cinnamaldehyde and thymol against Candida biofilms.

In vitro activities of carvacrol, cinnamaldehyde and thymol against Candida biofilms.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 20, 2021

Erratum for Miranda-Cadena et al., "Development and Characterization of Monoolein-Based Liposomes of Carvacrol, Cinnamaldehyde, Citral, or Thymol with Anti-Candida Activities".

Erratum for Miranda-Cadena et al., "Development and Characterization of Monoolein-Based Liposomes of Carvacrol, Cinnamaldehyde, Citral, or Thymol with Anti-Candida Activities".

Journal: Antimicrobial agents and chemotherapy

Published: May 19, 2021

Candida duobushaemulonii: An Old But Unreported Pathogen.

Candida duobushaemulonii: An Old But Unreported Pathogen.

Journal: Journal of fungi (Basel, Switzerland)

Published: November 09, 2020

Development and Characterization of Monoolein-Based Liposomes of Carvacrol, Cinnamaldehyde, Citral, or Thymol with Anti-Candida Activities.

Development and Characterization of Monoolein-Based Liposomes of Carvacrol, Cinnamaldehyde, Citral, or Thymol with Anti-Candida Activities.

Journal: Antimicrobial agents and chemotherapy

Published: July 27, 2020

Utility of two PCR-RFLP-based techniques for identification of Candida parapsilosis complex blood isolates.

Utility of two PCR-RFLP-based techniques for identification of Candida parapsilosis complex blood isolates.

Journal: Mycoses

Published: September 08, 2019

Corrigendum: Antifungal Activity of the Human Uterine Cervical Stem Cells Conditioned Medium (hUCESC-CM) Against Candida albicans and Other Medically Relevant Species of Candida.

Corrigendum: Antifungal Activity of the Human Uterine Cervical Stem Cells Conditioned Medium (hUCESC-CM) Against Candida albicans and Other Medically Relevant Species of Candida.

Journal: Frontiers in microbiology

Published: May 09, 2019

Showing 1-12 of 21

Last Updated: 09/26/2026